Preliminary findings from the National Register of Antipsychotic Medication in Pregnancy

References

• Miller WJ, Bloom J, Resnick M. Prenatal care for pregnant chronic mentally ill patients. Hosp Community Psychiatry 1992; 43: 942–943
   PubMedGoogle Scholar
• Hearle J, McGrath J. Motherhood and schizophrenia. Women and schizophrenia, D Castle, J McGrath, J Kulkarni. Cambridge University Press, Cambridge 2000; 79–94
   Google Scholar
• Gregoire A, Pearson S. Risk of pregnancy when changing to atypical antipsychotics. Br J Psychiatry 2002; 180: 83–84
   PubMed Web of Science ®Google Scholar
• Dickson RA, Edwards A. Clozapine and fertility. Am J Psychiatry 1997; 154: 582–583
   PubMed Web of Science ®Google Scholar
• Sacker A, Done DJ, Crow TJ. Obstetric complications in children born to parents with schizophrenia: a meta analysis of case control studies. Psychol Med 1996; 26: 279–287
   PubMed Web of Science ®Google Scholar
• Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich L-A. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 2005; 162: 79–92
   PubMed Web of Science ®Google Scholar
• Webb R, Abel K, Pickles A, Appleby L. Mortality in offspring with psychotic disorders: a critical review and meta-analysis. Am J Psychiatry 2005; 162: 1045–1057
   PubMed Web of Science ®Google Scholar
• Nilsson E, Lichtenstein P, Cnattingius S, Murray RM, Hultman CM. Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr Res 2002; 58: 221–229
   PubMed Web of Science ®Google Scholar
• Mednick SA, Parnas J, Schulsinger F. The Copenhagen high-risk project, 1982–1986. Schizophr Bull 1987; 13: 485–495
   PubMed Web of Science ®Google Scholar
• Lewis SW, Murray RM. Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. J Psychiatr Res 1987; 21: 413–421
   PubMed Web of Science ®Google Scholar
• Viguera AC, Cohen LS, Baldessarini RJ, Nonacs R. Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can J Psychiatry 2002; 47: 426–436
   PubMed Web of Science ®Google Scholar
• Seeman MV. Gender differences in the prescribing of antipsychotic drugs. Am J Psychiatry 2004; 161: 1324–1333
   PubMed Web of Science ®Google Scholar
• Kerns LL. Treatment of mental disorders in pregnancy: a review of psychotropic drug risk and benefits. J Clin Psychopharmacol 1989; 9: 78–87
   PubMed Web of Science ®Google Scholar
• Sobel DE. Fetal damage due to ECT, insulin coma, chlorpromazine, or reserpine. Arch Gen Psychiatry 1960; 2: 606–611
   Web of Science ®Google Scholar
• Patton SW, Misri S, Corral MR, Perry KF, Kuan AJ. Antipsychotic medication during pregnancy and lactation in women with schizophrenia: evaluating the risk. Can J Psychiatry 2002; 47: 959–965
   PubMed Web of Science ®Google Scholar
• Altshuler LL, Cohen L, Szuba M, Burt VK, Gitlin M, Mintz J. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996; 153: 592–606
   PubMed Web of Science ®Google Scholar
• Grigoriadis S, Seeman MV. The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women. Can J Psychiatry 2002; 47: 437–442
   PubMed Web of Science ®Google Scholar
• Tenyi T, Trixler M, Keresztes Z. Quetiapine and pregnancy. Am J Psychiatry 2002; 159: 674
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Corbin LA, Fung MC. Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol 2000; 20: 399–403
   PubMed Web of Science ®Google Scholar
• Koren G, Cohn T, Chitayat D, et al. Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants. Am J Psychiatry 2002; 159: 136–137
   PubMed Web of Science ®Google Scholar
• Chang SS, Renshaw DC. Psychosis and pregnancy. Compr Ther 1986; 12: 36–41
   PubMedGoogle Scholar
• Krener P, Simmons MK, Hansen RL, Treat JN. Effect of pregnancy on psychosis: life circumstances and psychiatric symptoms. Int J Psychiatry Med 1989; 19: 65–84
   PubMed Web of Science ®Google Scholar
• Wrede G, Mednick SA, Huttunen MO, Nilsson CG. Pregnancy and delivery complications in the births of an unselected series of Finnish children with schizophrenic mothers. Acta Psychiatr Scand 1980; 62: 369–381
   PubMed Web of Science ®Google Scholar
• Anonymous. Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Am Acad Pediatr 2000; 105:880–887.
   PubMed Web of Science ®Google Scholar
• Webb RT, Howard L, Abel KM. Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum. Cochrane Database Syst Rev 2004; 2: CD004411
   Google Scholar
• Vajda F, Lander C, O'Brien T, et al. Australian Pregnancy Registry of women taking antiepileptic drugs. Epilepsia 2004; 45: 1466
   PubMed Web of Science ®Google Scholar
• Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150: 782–786
   PubMed Web of Science ®Google Scholar
• Kumar R, Robson KM, Smith AM. Development of a self-administered questionnaire to measure maternal adjustment and maternal attitudes during pregnancy and after delivery. J Psychosom Res 1984; 28: 43–51
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261–276
   PubMed Web of Science ®Google Scholar